27 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Abbott's (ABT) Assert-IQ Cardiac Monitor Receives CE Mark https://www.zacks.com/stock/news/2246922/abbott-s-abt-assert-iq-cardiac-monitor-receives-ce-mark?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2246922 Mar 27, 2024 - Abbott's (ABT) Assert-IQ ICM enables regular monitoring for abnormal heart rhythms, as well as technologies to improve data management and workflow.
Abbott (ABT) Expands in Canada With First Eterna SCS Use https://www.zacks.com/stock/news/2245409/abbott-abt-expands-in-canada-with-first-eterna-scs-use?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2245409 Mar 25, 2024 - Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.
Here's Why Investors Should Retain Abbott (ABT) Stock Now https://www.zacks.com/stock/news/2243034/here-s-why-investors-should-retain-abbott-abt-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2243034 Mar 19, 2024 - Investors are optimistic about Abbott (ABT), led by solid prospects in the Diagnostic business and robust adoption of FreeStyle Libre.
Abbott (ABT) to Reduce Childhood Malnutrition With New Pact https://www.zacks.com/stock/news/2237550/abbott-abt-to-reduce-childhood-malnutrition-with-new-pact?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2237550 Mar 07, 2024 - Abbott's (ABT) latest partnership supports its sustainability goal of transforming care for malnutrition and improving the lives of 3 billion people per year by the decade's end.
Top Analyst Reports for Microsoft, Amazon.com & Berkshire Hathaway https://www.zacks.com/commentary/2230125/top-analyst-reports-for-microsoft-amazon-com-berkshire-hathaway?cid=CS-ZC-FT-research_daily-2230125 Feb 22, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Amazon.com, Inc. (AMZN) and Berkshire Hathaway Inc. (BRK.B).
Insulet's (PODD) Omnipod 5 Gets CE Mark for Added Compatibility https://www.zacks.com/stock/news/2223400/insulet-s-podd-omnipod-5-gets-ce-mark-for-added-compatibility?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2223400 Feb 08, 2024 - Insulet's (PODD) tubeless automated insulin delivery system's CE mark approval with multiple CGM sensor brands is likely to serve a wider patient pool.
HAE vs. ABT: Which Stock Is the Better Value Option? https://www.zacks.com/stock/news/2221954/hae-vs-abt-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2221954 Feb 06, 2024 - HAE vs. ABT: Which Stock Is the Better Value Option?
Top Research Reports for Abbott, T-Mobile & Booking https://www.zacks.com/commentary/2219543/top-research-reports-for-abbott-t-mobile-booking?cid=CS-ZC-FT-research_daily-2219543 Feb 01, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), T-Mobile US, Inc. (TMUS) Booking Holdings Inc. (BKNG).
Abbott Laboratories (ABT) Q4 2023 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/01/24/abbott-laboratories-abt-q4-2023-earnings-call-tran/?source=iedfolrf0000001 Jan 24, 2024 - ABT earnings call for the period ending December 31, 2023.
Q4 Earnings Roundup: ABT, GD, KMB & More https://www.zacks.com/stock/news/2215065/q4-earnings-roundup-abt-gd-kmb-more?cid=CS-ZC-FT-ahead_of_wall_street-2215065 Jan 24, 2024 - A spot-check of early morning Q4 reports show some earnings misses and revenue beats; Tesla and others report after the close.

Pages: 123

Page 1>